$52.29
-1.91-3.52%
At close: -
$53.99
1.703.25%
After Hours: Mar 19, 4:46 PM EDT
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
ProShares Ultra Nasdaq Biotechnology Stock Price, Quotes and Forecasts
BIBNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
60.83M
Fund Score
ProShares Ultra Nasdaq Biotechnology Price, Quotes and Forecasts | NASDAQ:BIB | Benzinga
Explore ProShares Ultra Nasdaq Biotechnology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BIB.
| Open | $53.51 |
| High | $53.51 |
| 52 Wk High | $69.56 |
| AUM | 60.83M |
| Dividend | $0.46 |
| Ex-Div Date | Jun 26, 2024 |
| Volume | 4.05K |
| Market Cap | $45.89B |
| Mgmt Fee | 0.75% |
| P/E Ratio | 26.79 |
| Prev. Close | $54.20 |
| Low | $51.85 |
| 52 Wk Low | $47.20 |
| Shares Out | 1.63M |
| Yield | 0.74% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 16.03K |
| Beta | 1.40 |
| Avg. Expense Ratio | 0.95% |
| P/B Ratio | 3.74 |
Recent News
FAQ
Q
How do I buy ProShares Ultra Nasdaq Biotechnology (BIB) stock?
A
You can purchase shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) through any online brokerage.
Q
Who are ProShares Ultra Nasdaq Biotechnology (BIB) competitors?
A
There are no as such competitors for ProShares Ultra Nasdaq Biotechnology.
Q
What is the forecast, or price target, for ProShares Ultra Nasdaq Biotechnology (BIB) stock?
A
There is no analysis for ProShares Ultra Nasdaq Biotechnology to provide a consensus price target.
Q
What is the current price for ProShares Ultra Nasdaq Biotechnology (BIB)?
A
The stock price for ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB) is $53.99 last updated March 19, 2025 at 4:46 PM EDT.
Q
Does ProShares Ultra Nasdaq Biotechnology (BIB) pay a dividend?
A
A quarterly cash dividend of 0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on September 28, 2010 to stockholders of record on September 21, 2010.
Q
When is ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) reporting earnings?
A
ProShares Ultra Nasdaq Biotechnology does not have any upcoming earnings scheduled.
Q
Is ProShares Ultra Nasdaq Biotechnology (BIB) going to split?
A
There is no upcoming split for ProShares Ultra Nasdaq Biotechnology.
| Open | $53.51 |
| High | $53.51 |
| 52 Wk High | $69.56 |
| AUM | 60.83M |
| Dividend | $0.46 |
| Ex-Div Date | Jun 26, 2024 |
| Volume | 4.05K |
| Market Cap | $45.89B |
| Mgmt Fee | 0.75% |
| P/E Ratio | 26.79 |
| Prev. Close | $54.20 |
| Low | $51.85 |
| 52 Wk Low | $47.20 |
| Shares Out | 1.63M |
| Yield | 0.74% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 16.03K |
| Beta | 1.40 |
| Avg. Expense Ratio | 0.95% |
| P/B Ratio | 3.74 |
About ProShares Trust
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Trading-Leveraged Equity |
| Fund Inception | Apr 6, 2010 |
| Managers | Tarak Dave Charles Lowery Alexander Ilyasov Scott Hanson Michael Neches |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Investment Policy
The Fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target.
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2025 Benzinga | All Rights Reserved